lidocaine has been researched along with Genetic Predisposition in 6 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We demonstrate that lidocaine may suppress Brugada syndrome associated with the N406S mutation by preventing the sodium channel from accumulating in the intermediate inactivation state." | 7.74 | A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome. ( Ashihara, T; Horie, M; Imoto, K; Ito, M; Itoh, H; Jo, H; Nagaoka, I; Nakazawa, Y; Oka, Y; Sakaguchi, T; Tsuji, K; Yao, T, 2007) |
| "To determine clinical features, outcome, risk factors for death, and efficacy of IV administration of lidocaine as a prophylactic treatment for ischemic reperfusion injury in gastric dilatation and volvulus (GDV) in dogs." | 7.74 | Evaluation of lidocaine treatment and risk factors for death associated with gastric dilatation and volvulus in dogs: 112 cases (1997-2005). ( Bdolah-Abram, T; Bruchim, Y; Buber, T; Epstein, A; Ranen, E; Saragusty, J, 2007) |
| "We demonstrate that lidocaine may suppress Brugada syndrome associated with the N406S mutation by preventing the sodium channel from accumulating in the intermediate inactivation state." | 3.74 | A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome. ( Ashihara, T; Horie, M; Imoto, K; Ito, M; Itoh, H; Jo, H; Nagaoka, I; Nakazawa, Y; Oka, Y; Sakaguchi, T; Tsuji, K; Yao, T, 2007) |
| "To determine clinical features, outcome, risk factors for death, and efficacy of IV administration of lidocaine as a prophylactic treatment for ischemic reperfusion injury in gastric dilatation and volvulus (GDV) in dogs." | 3.74 | Evaluation of lidocaine treatment and risk factors for death associated with gastric dilatation and volvulus in dogs: 112 cases (1997-2005). ( Bdolah-Abram, T; Bruchim, Y; Buber, T; Epstein, A; Ranen, E; Saragusty, J, 2007) |
| "Chronic postsurgical pain (CPSP) is an important and well recognized cause of much long-term suffering, which in some cases may be preventable and affects many people living with cancer." | 2.58 | Chronic postsurgical pain and cancer: the catch of surviving the unsurvivable. ( Bhaskar, A; Humble, SR; Jayaweera, A; Varela, N, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Humble, SR | 1 |
| Varela, N | 1 |
| Jayaweera, A | 1 |
| Bhaskar, A | 1 |
| Ogawa, R | 1 |
| Kishi, R | 1 |
| Takagi, A | 1 |
| Sakaue, I | 1 |
| Takahashi, H | 1 |
| Matsumoto, N | 1 |
| Masuhara, K | 1 |
| Nakazawa, K | 1 |
| Kobayashi, S | 1 |
| Miyake, F | 1 |
| Echizen, H | 1 |
| Itoh, H | 1 |
| Tsuji, K | 1 |
| Sakaguchi, T | 1 |
| Nagaoka, I | 1 |
| Oka, Y | 1 |
| Nakazawa, Y | 1 |
| Yao, T | 1 |
| Jo, H | 1 |
| Ashihara, T | 1 |
| Ito, M | 1 |
| Horie, M | 1 |
| Imoto, K | 1 |
| Buber, T | 1 |
| Saragusty, J | 1 |
| Ranen, E | 1 |
| Epstein, A | 1 |
| Bdolah-Abram, T | 1 |
| Bruchim, Y | 1 |
| Clancy, CE | 1 |
| Wehrens, XH | 1 |
| Surber, R | 1 |
| Hensellek, S | 1 |
| Prochnau, D | 1 |
| Werner, GS | 1 |
| Benndorf, K | 1 |
| Figulla, HR | 1 |
| Zimmer, T | 1 |
1 review available for lidocaine and Genetic Predisposition
| Article | Year |
|---|---|
Chronic postsurgical pain and cancer: the catch of surviving the unsurvivable.
Topics: Analgesics; Analgesics, Opioid; Cancer Pain; Chronic Pain; Drug Therapy, Combination; Gabapentin; Ge | 2018 |
5 other studies available for lidocaine and Genetic Predisposition
| Article | Year |
|---|---|
A novel microsatellite polymorphism of sodium channel beta1-subunit gene (SCN1B) may underlie abnormal cardiac excitation manifested by coved-type ST-elevation compatible with Brugada syndrome in Japanese.
Topics: Adult; Age Factors; Aged; Asian People; Brugada Syndrome; Electrocardiography; Female; Genetic Predi | 2010 |
A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Computer Simulation; Genetic Predisposition to Disease; Hu | 2007 |
Evaluation of lidocaine treatment and risk factors for death associated with gastric dilatation and volvulus in dogs: 112 cases (1997-2005).
Topics: Animals; Breeding; Dog Diseases; Dogs; Female; Gastric Dilatation; Genetic Predisposition to Disease | 2007 |
Mutation-specific effects of lidocaine in Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Genetic Predisposition to Disease; Humans; Lidocaine; Musc | 2007 |
Combination of cardiac conduction disease and long QT syndrome caused by mutation T1620K in the cardiac sodium channel.
Topics: Action Potentials; Adolescent; Adult; Ajmaline; Animals; Anti-Arrhythmia Agents; Bundle-Branch Block | 2008 |